Text Size

Detection and Characterization of Lower Respiratory Infections in Critically Ill Patients

This study is currently recruiting participants.
Verified February 2013 by Asan Medical Center
Sponsor:
Information provided by (Responsible Party):
Sang-Ho Choi, Asan Medical Center
ClinicalTrials.gov Identifier:
NCT01068990
First received: February 12, 2010
Last updated: February 11, 2013
Last verified: February 2013
History of Changes
  Purpose

This study is a prospective observation study for lower respiratory tract infections in medical intensive care unit. Microbiologic and clinical characteristics and outcomes of patients with severe pneumonia in medical intensive care unit will be monitored and analyzed.


Condition
Severe Pneumonia

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Detection and Characterization of Lower Respiratory Infections in Critically Ill Patients

Resource links provided by NLM:

MedlinePlus related topics: Pneumonia
U.S. FDA Resources

Further study details as provided by Asan Medical Center:

Primary Outcome Measures:
  • Identification of etiology of pneumonia [ Time Frame: 7 day from the time of pneumonia diagnosis ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Pneumonia-related death [ Time Frame: 1 month ] [ Designated as safety issue: No ]

Estimated Enrollment: 300
Study Start Date: March 2010
Estimated Study Completion Date: February 2016
Estimated Primary Completion Date: February 2016 (Final data collection date for primary outcome measure)
Detailed Description:

All patients admitting medical ICU will be monitored for pneumonia. Both community-acquired (including health-care associated pneumonia) and hospital-acquired pneumonia will be included. Collecting data will include patient demographic characteristics, clinical features, microbiological characteristics including molecular work, and outcome.

  Eligibility

Ages Eligible for Study:   16 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients admitting or admitted in medical ICU with pneumonia

Criteria

Inclusion Criteria:

  • Patients admitting medical ICU with pneumonia
  • Medical ICU admitted patients who is developed new pneumonia

Exclusion Criteria:

  • Patients already treated more than 48 hours for pneumonia in transferring hospital and no causative organism is isolated
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01068990

Contacts
Contact: Sang-Ho Choi, MD +82-2-3010-3304 sangho@amc.seoul.kr

Locations
Korea, Republic of
Asan Medical Center Recruiting
Seoul, Korea, Republic of, 138-736
Principal Investigator: Sang-Ho Choi, MD            
Sponsors and Collaborators
Asan Medical Center
Investigators
Principal Investigator: Sang-Ho Choi, MD Asan Medical Center
  More Information

No publications provided

Responsible Party: Sang-Ho Choi, Doctor, Asan Medical Center
ClinicalTrials.gov Identifier: NCT01068990     History of Changes
Other Study ID Numbers: AICUP
Study First Received: February 12, 2010
Last Updated: February 11, 2013
Health Authority: Korea: Institutional Review Board

Keywords provided by Asan Medical Center:
pneumonia

Additional relevant MeSH terms:
Critical Illness
Pneumonia
Respiratory Tract Infections
Disease Attributes
 Pathologic Processes
Lung Diseases
Respiratory Tract Diseases
Infection

ClinicalTrials.gov processed this record on May 22, 2013